Resistance Training in Advanced Cancer Patients Undergoing Tyrosine Kinase Inhibitor Therapy: A Clinical Feasibility Study

被引：0
|
作者：
Scharhag-Rosenberger, Friederike [1 ]
Schembri, Emanuel [1 ]
Vallet, Sonia [1 ]
Gruellich, Carsten [1 ]
Wiskemann, Joachim [1 ]
机构：
[1] Heidelberg Univ Hosp, Natl Ctr Tumor Dis NCT, Heidelberg, Germany
来源：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2016年 / 48卷 / 05期
关键词：
D O I：
10.1249/01.mss.0000486543.26635.2d
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
1870
引用
收藏
页码：513 / 513
页数：1
相关论文
共 50 条
  • [1] Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy—a controlled feasibility trial
    F. Rosenberger
    J. Wiskemann
    S. Vallet
    G. M. Haag
    E. Schembri
    D. Jäger
    C. Grüllich
    Supportive Care in Cancer, 2017, 25 : 3655 - 3664
  • [2] Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy-a controlled feasibility trial
    Rosenberger, F.
    Wiskemann, J.
    Vallet, S.
    Haag, G. M.
    Schembri, E.
    Jaeger, D.
    Gruellich, C.
    SUPPORTIVE CARE IN CANCER, 2017, 25 (12) : 3655 - 3664
  • [3] Continuation therapy with the tyrosine kinase inhibitor Imatinib for patients with advanced GIST
    Oechsle, K.
    Bokemeyer, C.
    ONKOLOGE, 2007, 13 (08): : 743 - 744
  • [4] Tyrosine kinase inhibitor therapy in a case of locally advanced differentiated thyroid cancer
    Stewart, Kirsten
    Strachan, Mark
    Srinivasan, Dev
    MacNeill, Morna
    Wall, Lucy
    Nixon, Iain
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 14 - 14
  • [5] Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients
    Lechner, Melissa G.
    Vyas, Chirag M.
    Hamnvik, Ole-Petter R.
    Alexander, Erik K.
    Larsen, P. Reed
    Choueiri, Toni K.
    Angell, Trevor E.
    THYROID, 2018, 28 (04) : 437 - 444
  • [6] Predictive factors for response and for resistance to tyrosine kinase inhibitor therapy in lung cancer
    Cappuzzo, Federico
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) : S12 - S14
  • [7] Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
    Liu, Chenming
    Chen, Jintao
    Liu, Yuxing
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [8] A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer
    Ebert, M
    Nitsche, B
    Roecken, C
    Fahlke, J
    Hosius, C
    Gschaidmeier, H
    Kahl, S
    Lippert, H
    Malfertheiner, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 351S - 351S
  • [9] Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a series
    Stewart, Kirsten E.
    Strachan, Mark W. J.
    Srinivasan, Devraj
    MacNeill, Morna
    Wall, Lucy
    Nixon, Iain J.
    BRITISH JOURNAL OF SURGERY, 2022, 109
  • [10] Tyrosine Kinase Inhibitor Therapy in Locally Advanced Differentiated Thyroid Cancer: A Case Report
    Stewart, Kirsten E.
    Strachan, Mark W. J.
    Srinivasan, Devraj
    MacNeill, Morna
    Wall, Lucy
    Nixon, Iain J.
    EUROPEAN THYROID JOURNAL, 2019, 8 (02) : 102 - 107
12345